Venlafaxine Hydrochloride | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Venlafaxine Hydrochloride
Health Canada Patents

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

Contact Supplier

IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

Contact Supplier

medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.

Contact Supplier

Coral

Contact Supplier

ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

Contact Supplier

Venlafaxine Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

89 API Suppliers, 42 USDMF, 45 CEP/COS, 3 JDMF, 20 EU WC, 6 KDMF, 20 NDC API, 32 Listed Suppliers, $ API Reference Price

89 API Suppliers
42 USDMF
45 CEP/COS
3 JDMF
20 EU WC
6 KDMF
20 NDC API
32 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

10 Drugs in Development

10 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

274 FDF Dossiers, 183 FDA Orange Book, 14 Europe, 46 Canada, 7 South Africa, 24 Listed Dossiers

274 FDF Dossiers
183 FDA Orange Book
14 Europe
46 Canada
7 South Africa
24 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, EXTENDED RELEASE;ORAL - EQ 150MG BASE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 37.5MG BASE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 75MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 150MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 225MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 37.5MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 75MG BASE

CAPSULE, EXTENDED RELEASE;ORAL - EQ 150MG BASE
CAPSULE, EXTENDED RELEASE;ORAL - EQ 37.5MG BASE
CAPSULE, EXTENDED RELEASE;ORAL - EQ 75MG BASE
TABLET, EXTENDED RELEASE;ORAL - EQ 150MG BASE
TABLET, EXTENDED RELEASE;ORAL - EQ 225MG BASE
TABLET, EXTENDED RELEASE;ORAL - EQ 37.5MG BASE
TABLET, EXTENDED RELEASE;ORAL - EQ 75MG BASE

RELATED EXCIPIENT COMPANIES

1 Minakem, 13 Evonik, 2 Rochem International Inc, 20 SPI Pharma, 12 DKSH, 1 Pharm-RX Chemical, 10 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 10 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 4 Kirsch Pharma, 4 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 3 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 39 BASF, 2 CD Formulation, 2 Clariant, 16 Corel Pharma Chem, 7 DFE Pharma, 1 Esteem Industries, 2 Finar, 13 Gangwal Chemicals, 9 Ideal Cures, 5 Ingredion Pharma Solutions, 26 Kerry, 3 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 1 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 25 Roquette, 17 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 3 Valens Pharmachem, 4 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

84 Fillers, Diluents & Binders, 76 Coating Systems & Additives, 46 Controlled & Modified Release, 46 Disintegrants & Superdisintegrants, 44 Direct Compression, 42 Thickeners and Stabilizers, 39 Solubilizers, 38 Granulation, 33 Taste Masking, 30 Topical, 26 Film Formers & Plasticizers, 24 Lubricants & Glidants, 23 Parenteral, 21 Chewable & Orodispersible Aids, 16 Co-Processed Excipients, 12 Emulsifying Agents, 10 Surfactant & Foaming Agents, 10 Rheology Modifiers, 9 Empty Capsules, 9 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules

84 Fillers, Diluents & Binders
76 Coating Systems & Additives
46 Controlled & Modified Release
46 Disintegrants & Superdisintegrants
44 Direct Compression
42 Thickeners and Stabilizers
39 Solubilizers
38 Granulation
33 Taste Masking
30 Topical
26 Film Formers & Plasticizers
24 Lubricants & Glidants
23 Parenteral
21 Chewable & Orodispersible Aids
16 Co-Processed Excipients
12 Emulsifying Agents
10 Surfactant & Foaming Agents
10 Rheology Modifiers
9 Empty Capsules
9 API Stability Enhancers
5 Coloring Agents
4 Vegetarian Capsules

DIGITAL CONTENT

28 News #PharmaBuzz

28 News #PharmaBuzz

GLOBAL SALES INFORMATION

39 US Medicaid Prescriptions, 32 Regulatory FDF Prices

39 US Medicaid Prescriptions
32 Regulatory FDF Prices

MARKET PLACE

10 APIs, 1 FDF Dossiers, 1 EXCIPIENTS

10 APIs
1 FDF Dossiers
1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

6 Health Canada Patents

6 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP

2 EDQM
2 USP

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 83 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

6 All

01 6Pfizer Canada Inc.

filter Patent Reset all filters

6 All

01 32126305

02 32199778

filter Product Reset all filters

6 All

01 6Venlafaxine Hydrochloride

filter Dosage Reset all filters

6 All

01 6Extended Release Capsules

filter Exp Date Reset all filters

6 All

01 32014-06-20

02 32017-03-12

Product Main Page

01

Pfizer Canada Inc.

Venlafaxine Hydrochloride

PackExpo

Not Confirmed

Pfizer Canada Inc.

PackExpo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-06-20

Date Granted : 2006-10-17

Venlafaxine Hydrochloride

Brand Name : EFFEXOR XR

Patent Number : 2126305

Filing Date : 1994-06-20

Strength per Unit : 37.5mg

Dosage Form : Extended Release Capsules

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-06-20

Date Granted : 2006-10-17

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Pfizer Canada Inc.

Venlafaxine Hydrochloride

PackExpo

Not Confirmed

Pfizer Canada Inc.

PackExpo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-03-12

Date Granted : 2005-12-20

Venlafaxine Hydrochloride

Brand Name : EFFEXOR XR

Patent Number : 2199778

Filing Date : 1997-03-12

Strength per Unit : 37.5mg

Dosage Form : Extended Release Capsules

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2017-03-12

Date Granted : 2005-12-20

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Pfizer Canada Inc.

Venlafaxine Hydrochloride

PackExpo

Not Confirmed

Pfizer Canada Inc.

PackExpo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-06-20

Date Granted : 2006-10-17

Venlafaxine Hydrochloride

Brand Name : EFFEXOR XR

Patent Number : 2126305

Filing Date : 1994-06-20

Strength per Unit : 75mg

Dosage Form : Extended Release Capsules

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-06-20

Date Granted : 2006-10-17

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Pfizer Canada Inc.

Venlafaxine Hydrochloride

PackExpo

Not Confirmed

Pfizer Canada Inc.

PackExpo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-03-12

Date Granted : 2005-12-20

Venlafaxine Hydrochloride

Brand Name : EFFEXOR XR

Patent Number : 2199778

Filing Date : 1997-03-12

Strength per Unit : 75mg

Dosage Form : Extended Release Capsules

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2017-03-12

Date Granted : 2005-12-20

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Pfizer Canada Inc.

Venlafaxine Hydrochloride

PackExpo

Not Confirmed

Pfizer Canada Inc.

PackExpo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-06-20

Date Granted : 2006-10-17

Venlafaxine Hydrochloride

Brand Name : EFFEXOR XR

Patent Number : 2126305

Filing Date : 1994-06-20

Strength per Unit : 150mg

Dosage Form : Extended Release Capsules

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-06-20

Date Granted : 2006-10-17

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Pfizer Canada Inc.

Venlafaxine Hydrochloride

PackExpo

Not Confirmed

Pfizer Canada Inc.

PackExpo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-03-12

Date Granted : 2005-12-20

Venlafaxine Hydrochloride

Brand Name : EFFEXOR XR

Patent Number : 2199778

Filing Date : 1997-03-12

Strength per Unit : 150mg

Dosage Form : Extended Release Capsules

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2017-03-12

Date Granted : 2005-12-20

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!